Close Menu

NEW YORK (GenomeWeb) – Genetic Technologies and Swisstec today announced a deal to finalize a joint venture to create a new company.

The new company will enable GTG and Swisstec to develop a service platform using blockchain technology for medical services and personalized health management, the partners said, adding the JV will facilitate data management and AI-based services to improve health outcomes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.